CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Option exercise Chief Medical Officer acquired 6,000 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 4,955 shares at an average $45.00 ($222,995)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale President and CFO sold 10,000 shares at $40.00 ($400,000)
- 4 Open-market sale Chief Scientific Officer sold 10,000 shares at $40.00 ($400,000)
- 4 Open-market sale Chief Executive Officer sold 32,085 shares at an average $37.65 ($1,207,897)
- 4 Open-market sale Chief Executive Officer sold 13,033 shares at an average $36.28 ($472,887)
- 4 Open-market sale President and CFO sold 8,500 shares at an average $35.14 ($298,715)
- 4 Open-market sale President and CFO sold 7,500 shares at $33.02 ($247,650)
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale President and CFO sold 12,500 shares at an average $31.51 ($393,823)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 4,882 shares at an average $36.02 ($175,848)
- 4/A Open-market sale Director sold 44,895 shares at an average $34.00 ($1,526,467)
- 4 Open-market sale Chief Scientific Officer sold 10,000 shares at $35.00 ($350,000)
- 4 Open-market sale Chief Executive Officer sold 22,579 shares at an average $34.27 ($773,838)
- 4 Open-market sale Director sold 44,895 shares at an average $34.00 ($1,526,467)
- 4 Open-market sale Chief Business Officer sold 79,729 shares at an average $32.40 ($2,583,469)
Page 23 of 33 · 660 filings